AHA Coding Clinic® for ICD-9 - 2013 Issue 4; Ask the Editor
Injection of AmnioMatrix„
A patient with a nonhealing wound of the left lower leg underwent excisional debridement to healthy bleeding tissue. Amnio-matrix™ cells were injected along subcutaneous tissues within the wound as well as the periwound area, and a dressing was placed. What is the correct code assignment for placement of Amnio-matrix™ allograft cells into the leg wound? ...
Subscribe or sign in to view the full article.
Article Overview
This premium article explains coding considerations for a wound treatment scenario involving a biologic amniotic tissue product administered by injection or applied topically. It is intended for coding professionals who need to understand how the procedure is categorized, what kind of wound care context it falls under, and how related guidance may apply when reviewing documentation for billing and reporting purposes.
Why This Topic Matters
Accurate reporting of wound-related biologic product procedures depends on understanding the procedure category and the documentation context. This article helps coders and auditors recognize the broad coding framework for this type of service without having to rely on assumptions from the clinical narrative alone.
What You Will Learn
- How a wound-related biologic tissue product procedure is categorized
- What documentation context is relevant when reviewing the service
- How the article frames the general coding approach for this type of wound care scenario
- Why procedure classification matters for reporting and review
Who Should Read This
- medical coders
- coding auditors
- billing staff
- compliance professionals
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com